Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation

Pediatr Blood Cancer. 2008 Oct;51(4):569. doi: 10.1002/pbc.21626.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Child, Preschool
  • Follow-Up Studies
  • Humans
  • Leukemia, Myelomonocytic, Juvenile / drug therapy
  • Leukemia, Myelomonocytic, Juvenile / enzymology
  • Leukemia, Myelomonocytic, Juvenile / genetics*
  • Leukemia, Myelomonocytic, Juvenile / pathology*
  • Male
  • Mutation / genetics*
  • ras Proteins / genetics*
  • ras Proteins / metabolism

Substances

  • Antineoplastic Agents
  • ras Proteins